ultomiris
alexion europe sas - ravulizumab - hemoglobinuria, paroxysmal - selektivni imunosupresivi - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
omnipaque 647 mg/1 ml otopina za injekciju
amicus pharma d.o.o. - joheksol - otopina za injekciju - 647 mg/1 ml - 1 ml otopine za injekciju sadrži:647 mg joheksola (što odgovara 300 mg joda)
omnipaque 647 mg/1 ml otopina za injekciju
amicus pharma d.o.o. - joheksol - otopina za injekciju - 647 mg/1 ml - 1 ml otopine za injekciju sadrži: 647 mg joheksola, (što odgovara 300 mg joda)
omnipaque 755 mg/1 ml otopina za injekciju
amicus pharma d.o.o. - joheksol - otopina za injekciju - 755 mg/1 ml - 1 ml otopine za injekciju sadrži: 755 mg joheksola (što odgovara 350 mg joda)
omnipaque 755 mg/1 ml otopina za injekciju
amicus pharma d.o.o. - joheksol - otopina za injekciju - 755 mg/1 ml - 1 ml otopine za injekciju sadrži: 755 mg joheksola (što odgovara 350 mg joda)
omnipaque 755 mg/1 ml otopina za injekciju
amicus pharma d.o.o. - joheksol - otopina za injekciju - 755 mg/1 ml - 1 ml otopine za injekciju sadrži:755 mg joheksola (što odgovara 350 mg joda)
omnipaque 755 mg/1 ml otopina za injekciju
amicus pharma d.o.o. - joheksol - otopina za injekciju - 755 mg/1 ml - 1 ml otopine za injekciju sadrži:755 mg joheksola (što odgovara 350 mg joda)